The inductive UGM dictated NHPrE1/EV cells to form benign glandular structures (Figures 4C and 4F), whereas the NHPrE1/AR recombinants developed invasive carcinomas (Figures 4I and 4L). Here, AR is linked to invasive carcinoma.